PL2755964T3 - Sole kwasu sulfonowego imidazoli podstawionych heterocykliloamidem - Google Patents

Sole kwasu sulfonowego imidazoli podstawionych heterocykliloamidem

Info

Publication number
PL2755964T3
PL2755964T3 PL12761936.9T PL12761936T PL2755964T3 PL 2755964 T3 PL2755964 T3 PL 2755964T3 PL 12761936 T PL12761936 T PL 12761936T PL 2755964 T3 PL2755964 T3 PL 2755964T3
Authority
PL
Poland
Prior art keywords
heterocyclylamide
sulfonic acid
acid salts
substituted imidazoles
imidazoles
Prior art date
Application number
PL12761936.9T
Other languages
English (en)
Inventor
Wilfried Schwab
Guido Schiffer
Kurt Voegtli
Andreas Kyas
Gerd Osswald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46888404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2755964(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL2755964T3 publication Critical patent/PL2755964T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12761936.9T 2011-09-14 2012-09-12 Sole kwasu sulfonowego imidazoli podstawionych heterocykliloamidem PL2755964T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE201110113749 DE102011113749A1 (de) 2011-09-14 2011-09-14 Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole

Publications (1)

Publication Number Publication Date
PL2755964T3 true PL2755964T3 (pl) 2016-12-30

Family

ID=46888404

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12761936.9T PL2755964T3 (pl) 2011-09-14 2012-09-12 Sole kwasu sulfonowego imidazoli podstawionych heterocykliloamidem

Country Status (27)

Country Link
US (1) US9133165B2 (pl)
EP (1) EP2755964B1 (pl)
JP (1) JP6193860B2 (pl)
KR (1) KR101983416B1 (pl)
CN (1) CN103889973B (pl)
AU (1) AU2012307449B8 (pl)
BR (1) BR112014006196A2 (pl)
CA (1) CA2848806C (pl)
CY (1) CY1118487T1 (pl)
DE (1) DE102011113749A1 (pl)
DK (1) DK2755964T3 (pl)
ES (1) ES2593268T3 (pl)
HR (1) HRP20161186T1 (pl)
HU (1) HUE030091T2 (pl)
IL (1) IL231546A (pl)
LT (1) LT2755964T (pl)
MX (1) MX2014002921A (pl)
PH (1) PH12014500577A1 (pl)
PL (1) PL2755964T3 (pl)
PT (1) PT2755964T (pl)
RS (1) RS55191B1 (pl)
RU (1) RU2606639C2 (pl)
SG (1) SG11201400653PA (pl)
SI (1) SI2755964T1 (pl)
SM (1) SMT201600353B (pl)
WO (1) WO2013037812A1 (pl)
ZA (1) ZA201401911B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202200465T1 (it) 2016-07-14 2023-01-13 Crinetics Pharmaceuticals Inc Modulatori della somatostatina e loro usi
MX2019008230A (es) 2017-01-10 2019-10-24 Bayer Ag Derivados heterociclicos como agentes de control de plagas.
JP2022540922A (ja) * 2019-07-17 2022-09-20 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターの結晶形態
CN116456968B (zh) 2020-09-09 2026-03-20 克林提克斯医药股份有限公司 生长抑素调节剂的制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
US4337341A (en) * 1976-11-02 1982-06-29 Eli Lilly And Company 4a-Aryl-octahydro-1H-2-pyrindines
JPH07110852B2 (ja) * 1989-12-28 1995-11-29 ジ・アップジョン・カンパニー 二芳香族置換抗aids化合物
JP3817261B2 (ja) * 1994-04-15 2006-09-06 ファルマシア・アンド・アップジョン・カンパニー 1−[5−メタンスルホンアミドインドリル−2−カルボニル]−4−[3−(1−メチルエチルアミノ)−2−ピリジニル]ピペラジンの新規結晶形
AU723563B2 (en) * 1996-01-26 2000-08-31 Pharmacia & Upjohn Company Use of a combination of delavirdine and one or more protease inhibitors in HIV-1 infected patients
FR2842808B1 (fr) * 2002-07-25 2004-09-10 Sod Conseils Rech Applic Nouveaux derives d'arylimidazoles, leur preparation et leurs applications therapeutiques
DE10257358A1 (de) * 2002-12-09 2004-07-08 Bayer Healthcare Ag Substituierte Pyrrole
JP2007527394A (ja) * 2003-07-01 2007-09-27 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 拡散層調節固体
DE102005008183A1 (de) * 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole
US8524735B2 (en) * 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
DE102005033103A1 (de) * 2005-07-15 2007-01-25 Bayer Healthcare Ag Heterocyclylamid-substituierte Thiazole, Pyrrole und Thiophene
KR101549364B1 (ko) * 2006-03-17 2015-09-01 암비트 바이오사이언시즈 코포레이션 질환 치료용 이미다졸로티아졸 화합물

Also Published As

Publication number Publication date
RS55191B1 (sr) 2017-01-31
EP2755964A1 (de) 2014-07-23
AU2012307449B8 (en) 2017-03-23
AU2012307449A8 (en) 2017-03-23
SMT201600353B (it) 2016-11-10
JP6193860B2 (ja) 2017-09-06
SG11201400653PA (en) 2014-08-28
WO2013037812A1 (de) 2013-03-21
CN103889973A (zh) 2014-06-25
CN103889973B (zh) 2017-12-05
RU2014114381A (ru) 2015-10-20
AU2012307449B2 (en) 2017-02-23
KR101983416B1 (ko) 2019-05-28
ES2593268T3 (es) 2016-12-07
ZA201401911B (en) 2017-09-27
HRP20161186T1 (hr) 2016-11-04
LT2755964T (lt) 2016-10-10
SI2755964T1 (sl) 2016-10-28
BR112014006196A2 (pt) 2017-04-11
CY1118487T1 (el) 2017-07-12
EP2755964B1 (de) 2016-06-22
IL231546A (en) 2017-08-31
KR20140075711A (ko) 2014-06-19
PH12014500577A1 (en) 2022-05-02
US9133165B2 (en) 2015-09-15
PT2755964T (pt) 2016-09-23
MX2014002921A (es) 2014-08-27
HK1199033A1 (en) 2015-06-19
DK2755964T3 (en) 2016-08-29
IL231546A0 (en) 2014-04-30
CA2848806A1 (en) 2013-03-21
JP2014530180A (ja) 2014-11-17
DE102011113749A1 (de) 2013-03-14
US20140315924A1 (en) 2014-10-23
HUE030091T2 (en) 2017-04-28
AU2012307449A1 (en) 2014-04-10
CA2848806C (en) 2017-12-12
RU2606639C2 (ru) 2017-01-10

Similar Documents

Publication Publication Date Title
DK2685832T3 (da) Stabiliserede hypohalogensyreopløsninger
ZA201308086B (en) Derivatives of 1-anino-2-cyclopropylboronic acid
DK3050972T3 (da) Fremgangsmåder til fremstilling af eicosapentaensyre i thraustochytrider
GB201304499D0 (en) Carcainium Salts
ZA201401901B (en) Guanidinobenzoic acid compound
ZA201307135B (en) Cell for depolarised electrodialysis of salt solutions
EP2799494A4 (en) SOLUTION OF POLYAMIC ACID
EP2760853A4 (en) NEW SALTS OF ALOGLIPTIN
SMT201600071B (it) Derivato di acido pirrolidina-3-ilacetico
IL231714B (en) Sialic acid analogs
EP2663306A4 (en) POLYMORPHS OF DEXLANSOPRAZOLE SALTS
IL231546A (en) Salts of sulfonic acid of imidazoles conjugated with heterocyclic amide
ZA201401599B (en) Preparation of methacrylic acid
IL228574A (en) Benzoic acid salt of automixbenzene
EP2782902A4 (en) DERIVATIVES FROM PHENOXYISOBUTTERIC ACID
EP2768812A4 (en) BOSENTAN ACID ADDITION SALTS
EP2791349A4 (en) SYNTHESIS OF N-ACETYL-D-NEURAMIC ACID
EP2755989A4 (en) PROCESS FOR THE PREPARATION OF BETULINIC ACID
EP2755990A4 (en) PROCESS FOR THE PREPARATION OF BETULINIC ACID
EP2755991A4 (en) PROCESS FOR THE PREPARATION OF BETULINIC ACID
GB201105988D0 (en) Acid formation
GB201106819D0 (en) Novel salts